CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The HIV antiretroviral drug Viramune can cause sometimes deadly liver damage but remains a key option for many patients, U.S. health officials warned on Wednesday. The Food and Drug Administration said doctors should weigh benefits and risks before prescribing the nonnucleoside reverse transcriptase inhibitor, manufactured by Boehringer Ingelheim. No serious liver toxicity or deaths have been reported when a single dose was given to prevent mother-to-child transmission of the deadly HIV virus that causes AIDS, the FDA said. Viramune, also known by its generic name nevirapine, is distributed for that use in African countries as part of President George Bush's effort to fight the spread of AIDS. The name-brand drug is also used in the United States. Controversy has swirled recently in Africa, with South Africa's ruling African National Congress accusing U.S. officials of conspiring with Boehringer Ingelheim, a private company based in Germany, to hide nevirapine's side effects. U.S. health officials dispute the charge. The FDA, in a statement, said cases of liver damage that produce a rash, fever, or other symptoms were more common with nevirapine than with other HIV-fighting drugs. Some instances have been fatal, including some in pregnant women. Females and patients with higher counts of infection-fighting CD4 immune system cells have greater risks of developing liver damage, the FDA said. The FDA said side-effect warnings had recently been revised on the drug's prescribing information. "In spite of the potential for serious and life-threatening liver toxicity and skin rashes with nevirapine, there are multiple reasons why nevirapine remains an important part of an HIV treatment regimen for many HIV-infected individuals worldwide," the FDA said in a statement. A spokeswoman for Boehringer Ingelheim said there would be no change in the company's policy of offering Viramune free of charge to developing countries for preventing mother-to-child transmissions of HIV. "There is no consequence for our donation or for supply of the drug for continuous treatment at reduced prices in developing countries," the spokeswoman said. "We do not expect any major effects on the behavior of doctors or on our sales as a result of the FDA warning." (Reuters)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Lauren Boebert Caught Fondling Date’s Genitals During Family-Friendly Musical: Video
September 15 2023 11:20 PM
Don’t miss our latest news! Sign up today for our free newsletter.
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Incel Influencer Sneako’s Young Fans Yell ‘All Gays Should Die’ in Viral Video
September 19 2023 4:05 PM
Marjorie Taylor Greene Shares Fake Video of Pride Flag Tussle as If It's Real
September 19 2023 11:00 AM
Lauren Boebert Apparently Disinvited From Right-Wing Youth Conference Over Theater Scandal
September 18 2023 5:33 PM
It's Time to Pay Attention to Older Americans Living With HIV, Advocates Say
September 18 2023 2:00 PM
Kansas Librarians Sue After Being Fired Over Autism Display Mistaken for LGBTQ+ Support
September 18 2023 1:01 PM